Two Companies Show Great Promise in Fight against Parkinson’s Disease, Showcase Potential for Significant Growth
Noting the recent surge of biotechnology stocks, a recently article by Tom Meyer highlights two companies that show tremendous promise for offering new advanced treatments for Parkinson’s disease. These two companies, Acadia Pharmaceuticals and International Stem Cell Corp., are quickly emerging as attractive investment opportunities for investors on account of their innovation and growth potential. In 2012 existing treatments for Parkinson’s generated around $2.5 billion, one indicator of the market share potential for new, effective treatments for Parkinson’s. International Stem Cell Corp. is developing a leading-edge technology in the stem cell industry, parthenogenesis. This technology creates human pluripotent stem cells…